

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * positive regulation of gamma-delta T cell activation (GO:0046645) | 6.82331780 |
| 2 | * negative T cell selection (GO:0043383) | 6.32738670 |
| 3 | T cell migration (GO:0072678) | 5.82287676 |
| 4 | * negative thymic T cell selection (GO:0045060) | 5.81629253 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.78319791 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.78319791 |
| 7 | * negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.65312545 |
| 8 | * negative regulation of cell killing (GO:0031342) | 5.65312545 |
| 9 | interferon-gamma production (GO:0032609) | 5.56010312 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.49594489 |
| 11 | response to interleukin-15 (GO:0070672) | 5.48728770 |
| 12 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.47711353 |
| 13 | * positive thymic T cell selection (GO:0045059) | 5.37033532 |
| 14 | cellular response to interleukin-15 (GO:0071350) | 5.36117380 |
| 15 | * positive T cell selection (GO:0043368) | 5.30136615 |
| 16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.18948549 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.18948549 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 5.18948549 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 5.18948549 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 5.18948549 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.18948549 |
| 22 | * regulation of gamma-delta T cell differentiation (GO:0045586) | 5.17880910 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.06558330 |
| 24 | leukocyte aggregation (GO:0070486) | 5.01799312 |
| 25 | * T cell selection (GO:0045058) | 4.92264572 |
| 26 | * thymic T cell selection (GO:0045061) | 4.84846147 |
| 27 | * regulation of isotype switching to IgG isotypes (GO:0048302) | 4.84714734 |
| 28 | * regulation of gamma-delta T cell activation (GO:0046643) | 4.83862694 |
| 29 | * positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.83833734 |
| 30 | * regulation of B cell receptor signaling pathway (GO:0050855) | 4.70986380 |
| 31 | activated T cell proliferation (GO:0050798) | 4.58089634 |
| 32 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.50761765 |
| 33 | detection of molecule of bacterial origin (GO:0032490) | 4.40870888 |
| 34 | macrophage activation involved in immune response (GO:0002281) | 4.40676309 |
| 35 | cellular extravasation (GO:0045123) | 4.33316258 |
| 36 | detection of other organism (GO:0098543) | 4.29361552 |
| 37 | T cell costimulation (GO:0031295) | 4.19445427 |
| 38 | neutrophil activation involved in immune response (GO:0002283) | 4.16970746 |
| 39 | microglial cell activation (GO:0001774) | 4.16757442 |
| 40 | lymphocyte costimulation (GO:0031294) | 4.12079799 |
| 41 | * T cell receptor signaling pathway (GO:0050852) | 4.11504415 |
| 42 | regulation of T cell tolerance induction (GO:0002664) | 4.07438059 |
| 43 | positive regulation of interleukin-2 production (GO:0032743) | 4.06220471 |
| 44 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.02705980 |
| 45 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.02232140 |
| 46 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.02232140 |
| 47 | detection of external biotic stimulus (GO:0098581) | 3.99375667 |
| 48 | * negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.96498571 |
| 49 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.94773212 |
| 50 | * antigen receptor-mediated signaling pathway (GO:0050851) | 3.91783970 |
| 51 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.91036655 |
| 52 | tolerance induction (GO:0002507) | 3.89250616 |
| 53 | detection of bacterium (GO:0016045) | 3.88952442 |
| 54 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.87414917 |
| 55 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.87414917 |
| 56 | * positive regulation of isotype switching (GO:0045830) | 3.83650409 |
| 57 | * regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.81448602 |
| 58 | * regulation of alpha-beta T cell proliferation (GO:0046640) | 3.77409417 |
| 59 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.72823015 |
| 60 | * B cell receptor signaling pathway (GO:0050853) | 3.69889289 |
| 61 | mast cell activation (GO:0045576) | 3.67895276 |
| 62 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.64560414 |
| 63 | response to peptidoglycan (GO:0032494) | 3.62447843 |
| 64 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.60885011 |
| 65 | response to host immune response (GO:0052572) | 3.60885011 |
| 66 | myeloid cell activation involved in immune response (GO:0002275) | 3.57222478 |
| 67 | macrophage activation (GO:0042116) | 3.55484058 |
| 68 | detection of biotic stimulus (GO:0009595) | 3.54613952 |
| 69 | * regulation of B cell differentiation (GO:0045577) | 3.54427923 |
| 70 | lymphocyte migration (GO:0072676) | 3.53244581 |
| 71 | respiratory burst (GO:0045730) | 3.51844523 |
| 72 | neutrophil mediated immunity (GO:0002446) | 3.50666127 |
| 73 | * negative regulation of leukocyte mediated immunity (GO:0002704) | 3.48955487 |
| 74 | natural killer cell activation (GO:0030101) | 3.48079098 |
| 75 | * positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.45427375 |
| 76 | * positive regulation of B cell mediated immunity (GO:0002714) | 3.45427375 |
| 77 | * positive regulation of DNA recombination (GO:0045911) | 3.45395064 |
| 78 | positive regulation of B cell differentiation (GO:0045579) | 3.43971563 |
| 79 | regulation of regulatory T cell differentiation (GO:0045589) | 3.42106911 |
| 80 | NIK/NF-kappaB signaling (GO:0038061) | 3.41357585 |
| 81 | * leukocyte cell-cell adhesion (GO:0007159) | 3.36144744 |
| 82 | myeloid dendritic cell activation (GO:0001773) | 3.35824496 |
| 83 | response to host (GO:0075136) | 3.35344499 |
| 84 | response to host defenses (GO:0052200) | 3.35344499 |
| 85 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.35344499 |
| 86 | alpha-beta T cell activation (GO:0046631) | 3.32460631 |
| 87 | granulocyte activation (GO:0036230) | 3.28627198 |
| 88 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.27106461 |
| 89 | positive regulation of tolerance induction (GO:0002645) | 3.24836590 |
| 90 | * regulation of isotype switching (GO:0045191) | 3.24277077 |
| 91 | * positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.22860485 |
| 92 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.22574790 |
| 93 | regulation of response to interferon-gamma (GO:0060330) | 3.22123160 |
| 94 | myeloid leukocyte mediated immunity (GO:0002444) | 3.20895348 |
| 95 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.19811420 |
| 96 | dendritic cell migration (GO:0036336) | 3.19080423 |
| 97 | response to type I interferon (GO:0034340) | 3.19024430 |
| 98 | regulation of tolerance induction (GO:0002643) | 3.15195929 |
| 99 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.15010367 |
| 100 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.14660636 |
| 101 | * regulation of immunoglobulin mediated immune response (GO:0002889) | 3.14433183 |
| 102 | * regulation of B cell mediated immunity (GO:0002712) | 3.12317575 |
| 103 | T cell homeostasis (GO:0043029) | 3.12074482 |
| 104 | cellular response to type I interferon (GO:0071357) | 3.11688494 |
| 105 | type I interferon signaling pathway (GO:0060337) | 3.11688494 |
| 106 | alpha-beta T cell differentiation (GO:0046632) | 3.10538284 |
| 107 | * regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.08880861 |
| 108 | hepatocyte apoptotic process (GO:0097284) | 3.08549626 |
| 109 | regulation of interleukin-2 production (GO:0032663) | 3.08006265 |
| 110 | * regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.07527105 |
| 111 | * T cell proliferation (GO:0042098) | 3.06036629 |
| 112 | leukocyte degranulation (GO:0043299) | 3.05634368 |
| 113 | * negative regulation of T cell mediated immunity (GO:0002710) | 3.05433078 |
| 114 | dendritic cell chemotaxis (GO:0002407) | 3.04782382 |
| 115 | * T cell differentiation (GO:0030217) | 3.04681767 |
| 116 | response to muramyl dipeptide (GO:0032495) | 3.03257635 |
| 117 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.01781472 |
| 118 | positive regulation of mast cell activation (GO:0033005) | 3.01640249 |
| 119 | negative regulation of B cell proliferation (GO:0030889) | 3.01560217 |
| 120 | response to protozoan (GO:0001562) | 3.00615694 |
| 121 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.99872689 |
| 122 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.98821367 |
| 123 | mature B cell differentiation (GO:0002335) | 2.98487336 |
| 124 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.98001265 |
| 125 | defense response to protozoan (GO:0042832) | 2.97649385 |
| 126 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.97317225 |
| 127 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.97317225 |
| 128 | neutrophil activation (GO:0042119) | 2.96741419 |
| 129 | lymphocyte homeostasis (GO:0002260) | 2.95717070 |
| 130 | cellular defense response (GO:0006968) | 2.94633263 |
| 131 | myeloid dendritic cell differentiation (GO:0043011) | 2.93489330 |
| 132 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.93289862 |
| 133 | * regulation of cell killing (GO:0031341) | 2.92661084 |
| 134 | negative regulation of interleukin-12 production (GO:0032695) | 2.91624382 |
| 135 | * negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.91452862 |
| 136 | positive regulation of interferon-alpha production (GO:0032727) | 2.90444294 |
| 137 | * regulation of T cell mediated cytotoxicity (GO:0001914) | 2.90177390 |
| 138 | * T cell activation (GO:0042110) | 2.89431907 |
| 139 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.89299567 |
| 140 | * positive regulation of immunoglobulin production (GO:0002639) | 2.88336400 |
| 141 | regulation of mast cell degranulation (GO:0043304) | 2.87311631 |
| 142 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.84873948 |
| 143 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.84656489 |
| 144 | * regulation of lymphocyte mediated immunity (GO:0002706) | 2.82989976 |
| 145 | * positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.81796696 |
| 146 | positive regulation of granulocyte differentiation (GO:0030854) | 2.79456976 |
| 147 | immunoglobulin mediated immune response (GO:0016064) | 2.79377206 |
| 148 | * positive regulation of B cell activation (GO:0050871) | 2.78803554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.24220733 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.83694945 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.14804064 |
| 4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.21903828 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.80894327 |
| 6 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.80177283 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.49047166 |
| 8 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.46974609 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.45926650 |
| 10 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.39153812 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.26423544 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.17554189 |
| 13 | * MYB_26560356_Chip-Seq_TH2_Human | 3.11081236 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.07011767 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 3.05551227 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.94105346 |
| 17 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.93641887 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.76848121 |
| 19 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.76732073 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 2.68070123 |
| 21 | * MYB_26560356_Chip-Seq_TH1_Human | 2.63210565 |
| 22 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.58361181 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.45519847 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.38729617 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 2.36606876 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.25021869 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23965241 |
| 28 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.15656290 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.13931691 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.13801739 |
| 31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.10435462 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.04551259 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.99201195 |
| 34 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.94187557 |
| 35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.92702520 |
| 36 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.90432029 |
| 37 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87540816 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.86674346 |
| 39 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.81791946 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.77115787 |
| 41 | MAF_26560356_Chip-Seq_TH2_Human | 1.74812075 |
| 42 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.73768926 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67295491 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63336625 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61974161 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.61322342 |
| 47 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.50543785 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46426743 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43809707 |
| 50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.41979137 |
| 51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.40938183 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39445605 |
| 53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.38399634 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37202019 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36389317 |
| 56 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.36299412 |
| 57 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.36193479 |
| 58 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.35678310 |
| 59 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33324876 |
| 60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29405954 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28390275 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23639864 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21776026 |
| 64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16383848 |
| 65 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.13952677 |
| 66 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07513126 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06238622 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05390743 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05119541 |
| 70 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04722348 |
| 71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02250100 |
| 72 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.99149402 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98836474 |
| 74 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98227417 |
| 75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95941180 |
| 76 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95078915 |
| 77 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95003668 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94733474 |
| 79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92292647 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92278465 |
| 81 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.92005505 |
| 82 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91883297 |
| 83 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91558871 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90674995 |
| 85 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90373612 |
| 86 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.88810142 |
| 87 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88299456 |
| 88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87853744 |
| 89 | GATA1_22025678_ChIP-Seq_K562_Human | 0.87368210 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84795197 |
| 91 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.82461101 |
| 92 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.82418086 |
| 93 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.81513248 |
| 94 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80350596 |
| 95 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.78521319 |
| 96 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78158981 |
| 97 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.77192836 |
| 98 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72237788 |
| 99 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.71240890 |
| 100 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.69565716 |
| 101 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.68991037 |
| 102 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.68811550 |
| 103 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.67204751 |
| 104 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67146617 |
| 105 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66411184 |
| 106 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.66362588 |
| 107 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.65675236 |
| 108 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.64469572 |
| 109 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.63772203 |
| 110 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.62128037 |
| 111 | GATA3_26560356_Chip-Seq_TH1_Human | 0.61805348 |
| 112 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.60708205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.31969552 |
| 2 | * MP0003763_abnormal_thymus_physiology | 4.08783806 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.07451112 |
| 4 | MP0000685_abnormal_immune_system | 3.59092273 |
| 5 | * MP0001800_abnormal_humoral_immune | 3.37279227 |
| 6 | MP0009785_altered_susceptibility_to | 3.23402651 |
| 7 | MP0001790_abnormal_immune_system | 3.22453429 |
| 8 | MP0005387_immune_system_phenotype | 3.22453429 |
| 9 | MP0006082_CNS_inflammation | 3.16765337 |
| 10 | * MP0005000_abnormal_immune_tolerance | 3.13047072 |
| 11 | * MP0002723_abnormal_immune_serum | 2.93886546 |
| 12 | MP0003436_decreased_susceptibility_to | 2.93152694 |
| 13 | * MP0002420_abnormal_adaptive_immunity | 2.89358844 |
| 14 | * MP0002452_abnormal_antigen_presenting | 2.87153781 |
| 15 | * MP0001819_abnormal_immune_cell | 2.86260433 |
| 16 | * MP0005025_abnormal_response_to | 2.70703710 |
| 17 | * MP0002398_abnormal_bone_marrow | 2.66002359 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.64433422 |
| 19 | * MP0002405_respiratory_system_inflammati | 2.50715001 |
| 20 | MP0003303_peritoneal_inflammation | 2.42212237 |
| 21 | * MP0000716_abnormal_immune_system | 2.40002698 |
| 22 | * MP0002419_abnormal_innate_immunity | 2.39055780 |
| 23 | MP0002006_tumorigenesis | 2.34461983 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 2.32150736 |
| 25 | * MP0002148_abnormal_hypersensitivity_rea | 2.30655287 |
| 26 | MP0002396_abnormal_hematopoietic_system | 2.27044613 |
| 27 | MP0008260_abnormal_autophagy | 2.17767324 |
| 28 | * MP0000689_abnormal_spleen_morphology | 2.16356589 |
| 29 | * MP0000703_abnormal_thymus_morphology | 2.13734296 |
| 30 | * MP0002722_abnormal_immune_system | 2.11366619 |
| 31 | MP0001873_stomach_inflammation | 2.11116779 |
| 32 | MP0003300_gastrointestinal_ulcer | 2.10551079 |
| 33 | MP0010155_abnormal_intestine_physiology | 2.10242388 |
| 34 | MP0004947_skin_inflammation | 2.04535717 |
| 35 | MP0003724_increased_susceptibility_to | 1.98630354 |
| 36 | * MP0002429_abnormal_blood_cell | 1.94995678 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.92949157 |
| 38 | MP0001853_heart_inflammation | 1.82208445 |
| 39 | * MP0001845_abnormal_inflammatory_respons | 1.81906846 |
| 40 | MP0000858_altered_metastatic_potential | 1.74564980 |
| 41 | MP0004510_myositis | 1.66614105 |
| 42 | MP0002933_joint_inflammation | 1.62560312 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.56288781 |
| 44 | MP0005451_abnormal_body_composition | 1.53463094 |
| 45 | MP0004883_abnormal_blood_vessel | 1.52076969 |
| 46 | MP0003448_altered_tumor_morphology | 1.49901019 |
| 47 | * MP0003866_abnormal_defecation | 1.42323717 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.42282337 |
| 49 | MP0002132_abnormal_respiratory_system | 1.41997776 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.32573891 |
| 51 | MP0000465_gastrointestinal_hemorrhage | 1.32237747 |
| 52 | MP0008469_abnormal_protein_level | 1.29823320 |
| 53 | MP0005310_abnormal_salivary_gland | 1.27334361 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.26450310 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.26450310 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.22405644 |
| 57 | MP0009278_abnormal_bone_marrow | 1.17534636 |
| 58 | MP0001851_eye_inflammation | 1.16765526 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.15470090 |
| 60 | MP0003045_fibrosis | 1.14754457 |
| 61 | MP0008057_abnormal_DNA_replication | 1.14092106 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.12412291 |
| 63 | MP0003690_abnormal_glial_cell | 1.07481209 |
| 64 | MP0003787_abnormal_imprinting | 1.05379065 |
| 65 | MP0005164_abnormal_response_to | 1.03819605 |
| 66 | MP0004381_abnormal_hair_follicle | 1.02174891 |
| 67 | * MP0002019_abnormal_tumor_incidence | 1.01222764 |
| 68 | MP0005075_abnormal_melanosome_morpholog | 0.99975570 |
| 69 | MP0000490_abnormal_crypts_of | 0.99161209 |
| 70 | MP0000015_abnormal_ear_pigmentation | 0.99112775 |
| 71 | MP0010352_gastrointestinal_tract_polyps | 0.98095735 |
| 72 | * MP0002998_abnormal_bone_remodeling | 0.94683914 |
| 73 | MP0009764_decreased_sensitivity_to | 0.94090581 |
| 74 | MP0005166_decreased_susceptibility_to | 0.92738879 |
| 75 | MP0004130_abnormal_muscle_cell | 0.88739842 |
| 76 | MP0002009_preneoplasia | 0.85985881 |
| 77 | MP0005058_abnormal_lysosome_morphology | 0.85457874 |
| 78 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85393841 |
| 79 | MP0003075_altered_response_to | 0.78077683 |
| 80 | MP0009763_increased_sensitivity_to | 0.75677312 |
| 81 | MP0010307_abnormal_tumor_latency | 0.74460314 |
| 82 | MP0005076_abnormal_cell_differentiation | 0.71492472 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 0.69876977 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.69736057 |
| 85 | MP0005023_abnormal_wound_healing | 0.65925310 |
| 86 | MP0004484_altered_response_of | 0.64857268 |
| 87 | MP0000371_diluted_coat_color | 0.63709979 |
| 88 | MP0003077_abnormal_cell_cycle | 0.63245465 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.60118683 |
| 90 | MP0001986_abnormal_taste_sensitivity | 0.59555126 |
| 91 | MP0003091_abnormal_cell_migration | 0.58841145 |
| 92 | * MP0002136_abnormal_kidney_physiology | 0.58168566 |
| 93 | MP0003693_abnormal_embryo_hatching | 0.57049816 |
| 94 | MP0002095_abnormal_skin_pigmentation | 0.56677215 |
| 95 | MP0002332_abnormal_exercise_endurance | 0.55936735 |
| 96 | MP0009765_abnormal_xenobiotic_induced | 0.54737838 |
| 97 | MP0008874_decreased_physiological_sensi | 0.54389367 |
| 98 | MP0001663_abnormal_digestive_system | 0.53416873 |
| 99 | MP0001191_abnormal_skin_condition | 0.53052233 |
| 100 | MP0003828_pulmonary_edema | 0.52608582 |
| 101 | MP0008961_abnormal_basal_metabolism | 0.52328252 |
| 102 | MP0000604_amyloidosis | 0.51381627 |
| 103 | MP0003566_abnormal_cell_adhesion | 0.50619062 |
| 104 | MP0000249_abnormal_blood_vessel | 0.50171477 |
| 105 | MP0000343_altered_response_to | 0.49917846 |
| 106 | * MP0003795_abnormal_bone_structure | 0.49860931 |
| 107 | MP0005376_homeostasis/metabolism_phenot | 0.49725678 |
| 108 | MP0005390_skeleton_phenotype | 0.49609589 |
| 109 | MP0008877_abnormal_DNA_methylation | 0.49478652 |
| 110 | MP0010094_abnormal_chromosome_stability | 0.48209286 |
| 111 | MP0003252_abnormal_bile_duct | 0.48065942 |
| 112 | MP0002133_abnormal_respiratory_system | 0.46798857 |
| 113 | MP0002277_abnormal_respiratory_mucosa | 0.44930607 |
| 114 | * MP0000609_abnormal_liver_physiology | 0.44299705 |
| 115 | MP0000313_abnormal_cell_death | 0.44232808 |
| 116 | MP0003191_abnormal_cellular_cholesterol | 0.43395641 |
| 117 | MP0008058_abnormal_DNA_repair | 0.43069156 |
| 118 | MP0001243_abnormal_dermal_layer | 0.40223060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * T lymphocytopenia (HP:0005403) | 6.01954199 |
| 2 | * Abnormality of T cell number (HP:0011839) | 5.83684572 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.83082287 |
| 4 | Recurrent viral infections (HP:0004429) | 4.79916469 |
| 5 | Recurrent fungal infections (HP:0002841) | 4.76014948 |
| 6 | Severe combined immunodeficiency (HP:0004430) | 4.75082917 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.70681898 |
| 8 | Combined immunodeficiency (HP:0005387) | 4.46547539 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.37879533 |
| 10 | Stomatitis (HP:0010280) | 4.35634980 |
| 11 | Myositis (HP:0100614) | 4.29904011 |
| 12 | Recurrent bronchitis (HP:0002837) | 4.27933787 |
| 13 | * Abnormality of T cells (HP:0002843) | 4.27433729 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 4.24513137 |
| 15 | Nasal polyposis (HP:0100582) | 4.20482589 |
| 16 | Thyroiditis (HP:0100646) | 4.11776347 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 4.02981696 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.98300244 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.98300244 |
| 20 | Chronic otitis media (HP:0000389) | 3.82296106 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 3.80076920 |
| 22 | Optic neuritis (HP:0100653) | 3.80076920 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.78769466 |
| 24 | Mediastinal lymphadenopathy (HP:0100721) | 3.78538408 |
| 25 | IgM deficiency (HP:0002850) | 3.75684465 |
| 26 | IgG deficiency (HP:0004315) | 3.59988439 |
| 27 | Meningitis (HP:0001287) | 3.57710118 |
| 28 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.55244564 |
| 29 | Abnormality of the nasal mucosa (HP:0000433) | 3.52690451 |
| 30 | Vasculitis (HP:0002633) | 3.50688929 |
| 31 | Abnormality of eosinophils (HP:0001879) | 3.50488584 |
| 32 | Orchitis (HP:0100796) | 3.47321561 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 3.43481034 |
| 34 | Abnormality of the fingertips (HP:0001211) | 3.42084998 |
| 35 | Pustule (HP:0200039) | 3.40952423 |
| 36 | Abnormality of B cell number (HP:0010975) | 3.38907056 |
| 37 | B lymphocytopenia (HP:0010976) | 3.38907056 |
| 38 | Leukocytosis (HP:0001974) | 3.37752210 |
| 39 | Recurrent skin infections (HP:0001581) | 3.34993392 |
| 40 | Eosinophilia (HP:0001880) | 3.31520905 |
| 41 | Agammaglobulinemia (HP:0004432) | 3.25192817 |
| 42 | Lymphopenia (HP:0001888) | 3.19779532 |
| 43 | Inflammation of the large intestine (HP:0002037) | 3.15900129 |
| 44 | Chronic diarrhea (HP:0002028) | 3.12884572 |
| 45 | Obstructive lung disease (HP:0006536) | 3.12349158 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 3.12349158 |
| 47 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.10465176 |
| 48 | Pulmonary infiltrates (HP:0002113) | 3.04991191 |
| 49 | Gastrointestinal inflammation (HP:0004386) | 3.01326683 |
| 50 | Hypoplasia of the thymus (HP:0000778) | 2.95077281 |
| 51 | Encephalitis (HP:0002383) | 2.92436555 |
| 52 | Joint swelling (HP:0001386) | 2.90342115 |
| 53 | Abnormality of T cell physiology (HP:0011840) | 2.90111308 |
| 54 | Granulocytopenia (HP:0001913) | 2.88771948 |
| 55 | Arterial thrombosis (HP:0004420) | 2.87584093 |
| 56 | Urticaria (HP:0001025) | 2.87205018 |
| 57 | Hemoptysis (HP:0002105) | 2.85688029 |
| 58 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.84434935 |
| 59 | IgA deficiency (HP:0002720) | 2.83975552 |
| 60 | Colitis (HP:0002583) | 2.81174545 |
| 61 | Gastrointestinal infarctions (HP:0005244) | 2.80778812 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.77784774 |
| 63 | Thrombocytosis (HP:0001894) | 2.77436558 |
| 64 | Increased IgM level (HP:0003496) | 2.76067494 |
| 65 | Recurrent sinusitis (HP:0011108) | 2.72361136 |
| 66 | Abnormality of macrophages (HP:0004311) | 2.69958176 |
| 67 | Autoimmune hemolytic anemia (HP:0001890) | 2.66140394 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.65993272 |
| 69 | Periodontitis (HP:0000704) | 2.65265407 |
| 70 | Lymphoma (HP:0002665) | 2.64013075 |
| 71 | Abnormality of the prostate (HP:0008775) | 2.54178209 |
| 72 | Gingivitis (HP:0000230) | 2.54129549 |
| 73 | Peritonitis (HP:0002586) | 2.53060826 |
| 74 | Gastrointestinal stroma tumor (HP:0100723) | 2.52593352 |
| 75 | Cellulitis (HP:0100658) | 2.51651463 |
| 76 | Increased IgE level (HP:0003212) | 2.42437674 |
| 77 | Keratoconjunctivitis (HP:0001096) | 2.40279182 |
| 78 | Slow saccadic eye movements (HP:0000514) | 2.38807922 |
| 79 | Chest pain (HP:0100749) | 2.36064479 |
| 80 | Abnormality of the pleura (HP:0002103) | 2.34930504 |
| 81 | Viral hepatitis (HP:0006562) | 2.32542600 |
| 82 | Bronchitis (HP:0012387) | 2.31799193 |
| 83 | Epistaxis (HP:0000421) | 2.30052273 |
| 84 | Prolonged bleeding time (HP:0003010) | 2.29873267 |
| 85 | Verrucae (HP:0200043) | 2.29508642 |
| 86 | Papilloma (HP:0012740) | 2.29508642 |
| 87 | Acute hepatic failure (HP:0006554) | 2.25836985 |
| 88 | Episodic fever (HP:0001954) | 2.24914955 |
| 89 | Gingival bleeding (HP:0000225) | 2.22480346 |
| 90 | Chronic sinusitis (HP:0011109) | 2.22449679 |
| 91 | Papilledema (HP:0001085) | 2.20497869 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 2.19555529 |
| 93 | Glomerulopathy (HP:0100820) | 2.16726807 |
| 94 | Hypochromic anemia (HP:0001931) | 2.16147841 |
| 95 | Emphysema (HP:0002097) | 2.15390064 |
| 96 | Abnormal platelet volume (HP:0011876) | 2.12127206 |
| 97 | Subacute progressive viral hepatitis (HP:0006572) | 2.11946523 |
| 98 | Pulmonary embolism (HP:0002204) | 2.11754673 |
| 99 | Abnormality of the peritoneum (HP:0002585) | 2.10292790 |
| 100 | Keratitis (HP:0000491) | 2.07055409 |
| 101 | Abnormality of the endocardium (HP:0004306) | 2.03147800 |
| 102 | Amaurosis fugax (HP:0100576) | 2.01615194 |
| 103 | Stomach cancer (HP:0012126) | 2.01541075 |
| 104 | Cheilitis (HP:0100825) | 1.98246609 |
| 105 | Vertigo (HP:0002321) | 1.97784875 |
| 106 | Microcytic anemia (HP:0001935) | 1.93845898 |
| 107 | Sepsis (HP:0100806) | 1.93139764 |
| 108 | Hypochromic microcytic anemia (HP:0004840) | 1.92586349 |
| 109 | Restrictive lung disease (HP:0002091) | 1.92528598 |
| 110 | Skin ulcer (HP:0200042) | 1.91997107 |
| 111 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.90767488 |
| 112 | Polyneuropathy (HP:0001271) | 1.89943887 |
| 113 | Osteomyelitis (HP:0002754) | 1.86955177 |
| 114 | Gangrene (HP:0100758) | 1.86254638 |
| 115 | Arthralgia (HP:0002829) | 1.86174856 |
| 116 | Prostate neoplasm (HP:0100787) | 1.82128968 |
| 117 | Fatigue (HP:0012378) | 1.80966533 |
| 118 | Interstitial pulmonary disease (HP:0006530) | 1.80869987 |
| 119 | Hematochezia (HP:0002573) | 1.80254986 |
| 120 | Anorexia (HP:0002039) | 1.79372168 |
| 121 | Hepatitis (HP:0012115) | 1.77319428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.49471580 |
| 2 | TXK | 5.24159574 |
| 3 | ITK | 3.31340800 |
| 4 | JAK3 | 3.30051455 |
| 5 | MAP3K14 | 2.99568695 |
| 6 | TYK2 | 2.95724209 |
| 7 | ZAP70 | 2.63477830 |
| 8 | JAK1 | 2.55454641 |
| 9 | STK10 | 2.50926046 |
| 10 | IKBKE | 2.45139141 |
| 11 | FGFR4 | 2.17138410 |
| 12 | PRPF4B | 2.04432491 |
| 13 | IRAK4 | 1.96085172 |
| 14 | BLK | 1.95245328 |
| 15 | GRK6 | 1.90057871 |
| 16 | FGFR3 | 1.86863825 |
| 17 | LCK | 1.84736370 |
| 18 | TBK1 | 1.83648734 |
| 19 | TEC | 1.82810582 |
| 20 | MAP3K13 | 1.80318118 |
| 21 | SYK | 1.75753273 |
| 22 | BTK | 1.74727003 |
| 23 | KIT | 1.61612636 |
| 24 | HCK | 1.61291956 |
| 25 | NLK | 1.61090298 |
| 26 | IKBKB | 1.59874149 |
| 27 | RIPK4 | 1.52470124 |
| 28 | * CSK | 1.42547437 |
| 29 | MAP3K10 | 1.41136992 |
| 30 | BMPR2 | 1.35422718 |
| 31 | MARK3 | 1.32073760 |
| 32 | MST4 | 1.30751877 |
| 33 | PIK3CG | 1.29692733 |
| 34 | PRKCQ | 1.25968604 |
| 35 | CDK12 | 1.24244083 |
| 36 | CAMKK2 | 1.20487099 |
| 37 | CHUK | 1.15071555 |
| 38 | PIM1 | 1.14443797 |
| 39 | TGFBR2 | 1.13124492 |
| 40 | SIK2 | 1.10602335 |
| 41 | MAP3K1 | 1.09013122 |
| 42 | CSF1R | 1.07095520 |
| 43 | LRRK2 | 1.06854947 |
| 44 | EEF2K | 1.05702214 |
| 45 | LYN | 1.05527564 |
| 46 | CLK1 | 1.04947718 |
| 47 | IRAK3 | 1.02615599 |
| 48 | FES | 1.02045527 |
| 49 | MAP3K3 | 1.00958679 |
| 50 | JAK2 | 0.98867115 |
| 51 | RPS6KA4 | 0.97943961 |
| 52 | MAP3K2 | 0.96653372 |
| 53 | PRKCH | 0.96117130 |
| 54 | KSR2 | 0.91404330 |
| 55 | MATK | 0.89942707 |
| 56 | NME2 | 0.84209468 |
| 57 | MAP2K3 | 0.80030638 |
| 58 | EPHB1 | 0.77499890 |
| 59 | IRAK2 | 0.77456842 |
| 60 | MELK | 0.77047258 |
| 61 | CAMKK1 | 0.75657634 |
| 62 | MAP3K11 | 0.74402030 |
| 63 | TTN | 0.73320365 |
| 64 | NEK9 | 0.72976668 |
| 65 | MAP3K7 | 0.72588486 |
| 66 | WNK1 | 0.71724161 |
| 67 | BRD4 | 0.71505404 |
| 68 | SGK2 | 0.69221831 |
| 69 | STK4 | 0.68636650 |
| 70 | SIK3 | 0.65166041 |
| 71 | TAOK3 | 0.63292716 |
| 72 | PTK2B | 0.62203853 |
| 73 | PKN2 | 0.62073871 |
| 74 | PDGFRB | 0.60033920 |
| 75 | MAPK7 | 0.59998856 |
| 76 | CDK4 | 0.59654174 |
| 77 | MAP3K6 | 0.59549453 |
| 78 | TNK2 | 0.59542768 |
| 79 | TRPM7 | 0.57855224 |
| 80 | RAF1 | 0.57155447 |
| 81 | TESK2 | 0.56092711 |
| 82 | CDK9 | 0.54931126 |
| 83 | EPHA3 | 0.53434712 |
| 84 | NUAK1 | 0.52687578 |
| 85 | PDK1 | 0.51961004 |
| 86 | GRK7 | 0.51513481 |
| 87 | FLT3 | 0.50880699 |
| 88 | STK11 | 0.47590961 |
| 89 | ERN1 | 0.46781500 |
| 90 | MAP3K5 | 0.44855796 |
| 91 | PDPK1 | 0.44570843 |
| 92 | RET | 0.44518043 |
| 93 | IRAK1 | 0.44225954 |
| 94 | HIPK2 | 0.44198246 |
| 95 | ALK | 0.43111708 |
| 96 | DYRK1B | 0.40699457 |
| 97 | FYN | 0.38541483 |
| 98 | NEK6 | 0.37734801 |
| 99 | CDK6 | 0.37510243 |
| 100 | INSR | 0.37279432 |
| 101 | ABL1 | 0.37027615 |
| 102 | KSR1 | 0.36607142 |
| 103 | FRK | 0.36204330 |
| 104 | EGFR | 0.34701897 |
| 105 | IGF1R | 0.34674636 |
| 106 | PASK | 0.34013099 |
| 107 | KDR | 0.33477759 |
| 108 | STK38 | 0.33094981 |
| 109 | TGFBR1 | 0.32876785 |
| 110 | YES1 | 0.32838746 |
| 111 | GRK5 | 0.32651436 |
| 112 | CDC42BPA | 0.32592626 |
| 113 | CAMK4 | 0.32191550 |
| 114 | MAP2K6 | 0.31254450 |
| 115 | PTK6 | 0.29863684 |
| 116 | RPS6KA6 | 0.28581697 |
| 117 | MAPK12 | 0.28468077 |
| 118 | MAPK4 | 0.28393133 |
| 119 | TAOK1 | 0.28169915 |
| 120 | MAP3K8 | 0.27951690 |
| 121 | TRIB3 | 0.25431267 |
| 122 | PRKCD | 0.25141533 |
| 123 | ATR | 0.24743051 |
| 124 | MAPK3 | 0.24723189 |
| 125 | RPS6KA5 | 0.23972464 |
| 126 | MAPK11 | 0.23752641 |
| 127 | ACVR1B | 0.23293394 |
| 128 | SGK3 | 0.22769747 |
| 129 | MAPKAPK2 | 0.22644465 |
| 130 | TYRO3 | 0.22486227 |
| 131 | MARK2 | 0.21698888 |
| 132 | FGR | 0.19395291 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 4.39395847 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.22414861 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.06043539 |
| 4 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.98199178 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.95086222 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.78114016 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.68409139 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.64536502 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.62838222 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.50331906 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.44900421 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.43599643 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.24713702 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.15829533 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.75861195 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.75517445 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.74859998 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.72608583 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.72605461 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.70538743 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.70106233 |
| 22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.64389967 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.57326618 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.49576626 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46989945 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.43034714 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42646443 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.39907679 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.39599362 |
| 30 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.38790758 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36708080 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.35766897 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.34966764 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.32615189 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.30007196 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.28685732 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 1.25243179 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24922189 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.20800951 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.16378032 |
| 41 | Asthma_Homo sapiens_hsa05310 | 1.10806969 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.08994631 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03978587 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03826042 |
| 45 | HTLV-I infection_Homo sapiens_hsa05166 | 0.93656644 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91292229 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90751321 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.90627628 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.90138068 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 0.88856189 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88587728 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86418062 |
| 53 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.82943602 |
| 54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79798981 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79451828 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74300230 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74033795 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70524026 |
| 59 | Colorectal cancer_Homo sapiens_hsa05210 | 0.70495500 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70068017 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68541111 |
| 62 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65434845 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64026414 |
| 64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63768657 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60881929 |
| 66 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59100857 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59030129 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58140937 |
| 69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58013183 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56534370 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54769035 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54710931 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53570885 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51090944 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49487550 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49484940 |
| 77 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48029944 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47754324 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47403100 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46497139 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45690279 |
| 82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44350144 |
| 83 | Glioma_Homo sapiens_hsa05214 | 0.43555400 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43218599 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42709527 |
| 86 | Long-term potentiation_Homo sapiens_hsa04720 | 0.40503097 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38809389 |
| 88 | Lysosome_Homo sapiens_hsa04142 | 0.38330749 |
| 89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38024187 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37066160 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36751364 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.36635980 |
| 93 | Prostate cancer_Homo sapiens_hsa05215 | 0.36617188 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.35754536 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34292627 |
| 96 | Base excision repair_Homo sapiens_hsa03410 | 0.33891951 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31369554 |
| 98 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.30129665 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29473393 |
| 100 | RNA degradation_Homo sapiens_hsa03018 | 0.29010431 |
| 101 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.28867789 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28617155 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.25624666 |
| 104 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.25105717 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24987053 |
| 106 | Phagosome_Homo sapiens_hsa04145 | 0.24700738 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23456508 |
| 108 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.23073296 |
| 109 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.22980230 |
| 110 | Spliceosome_Homo sapiens_hsa03040 | 0.21966376 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | 0.21132903 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20961429 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.20089990 |
| 114 | Pathways in cancer_Homo sapiens_hsa05200 | 0.19822137 |
| 115 | Mismatch repair_Homo sapiens_hsa03430 | 0.19121099 |
| 116 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.19041817 |

